CN1037237C - "Qianliming" oculentum - Google Patents
"Qianliming" oculentum Download PDFInfo
- Publication number
- CN1037237C CN1037237C CN 94114836 CN94114836A CN1037237C CN 1037237 C CN1037237 C CN 1037237C CN 94114836 CN94114836 CN 94114836 CN 94114836 A CN94114836 A CN 94114836A CN 1037237 C CN1037237 C CN 1037237C
- Authority
- CN
- China
- Prior art keywords
- radix
- qianliming
- semen
- medicine
- flos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 claims abstract description 39
- 239000011505 plaster Substances 0.000 claims abstract description 10
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 241000628997 Flos Species 0.000 claims description 15
- 239000006071 cream Substances 0.000 claims description 13
- 239000003921 oil Substances 0.000 claims description 13
- 210000000582 semen Anatomy 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 239000002893 slag Substances 0.000 claims description 5
- 239000003053 toxin Substances 0.000 claims description 5
- 230000008030 elimination Effects 0.000 claims description 4
- 238000003379 elimination reaction Methods 0.000 claims description 4
- 241000717739 Boswellia sacra Species 0.000 claims description 3
- 244000293323 Cosmos caudatus Species 0.000 claims description 3
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 3
- 239000004863 Frankincense Substances 0.000 claims description 3
- 244000153234 Hibiscus abelmoschus Species 0.000 claims description 3
- 239000009636 Huang Qi Substances 0.000 claims description 3
- 235000015511 Liquidambar orientalis Nutrition 0.000 claims description 3
- 241001057584 Myrrha Species 0.000 claims description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 3
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 3
- 239000004870 Styrax Substances 0.000 claims description 3
- 244000028419 Styrax benzoin Species 0.000 claims description 3
- 235000000126 Styrax benzoin Nutrition 0.000 claims description 3
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 3
- 229930195729 fatty acid Natural products 0.000 claims description 3
- 239000000194 fatty acid Substances 0.000 claims description 3
- 150000004665 fatty acids Chemical class 0.000 claims description 3
- 235000008434 ginseng Nutrition 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 238000007670 refining Methods 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 241001062472 Stokellia anisodon Species 0.000 claims description 2
- 235000001361 Styrax officinalis Nutrition 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 235000019382 gum benzoic Nutrition 0.000 claims description 2
- 230000003647 oxidation Effects 0.000 claims description 2
- 238000007254 oxidation reaction Methods 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 238000004062 sedimentation Methods 0.000 claims description 2
- 244000131316 Panax pseudoginseng Species 0.000 claims 1
- 244000303379 Styrax officinalis Species 0.000 claims 1
- 239000012141 concentrate Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 13
- 229940079593 drug Drugs 0.000 abstract description 12
- 230000004436 pseudomyopia Effects 0.000 abstract description 7
- 239000002674 ointment Substances 0.000 abstract description 2
- 239000003885 eye ointment Substances 0.000 abstract 5
- 206010002198 Anaphylactic reaction Diseases 0.000 abstract 1
- 208000003455 anaphylaxis Diseases 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 241000411851 herbal medicine Species 0.000 abstract 1
- 231100000956 nontoxicity Toxicity 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 230000001954 sterilising effect Effects 0.000 abstract 1
- 238000004659 sterilization and disinfection Methods 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 208000001491 myopia Diseases 0.000 description 14
- 230000004379 myopia Effects 0.000 description 12
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 7
- 230000004438 eyesight Effects 0.000 description 7
- 238000001467 acupuncture Methods 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 206010020675 Hypermetropia Diseases 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 230000004305 hyperopia Effects 0.000 description 3
- 201000006318 hyperopia Diseases 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 241000208340 Araliaceae Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 208000030533 eye disease Diseases 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 241001096696 Alseodaphnopsis hainanensis Species 0.000 description 1
- 206010009185 Ciliary muscle spasm Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241001060310 Styracaceae Species 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930182482 anthraquinone glycoside Natural products 0.000 description 1
- 229940098421 anthraquinone glycoside Drugs 0.000 description 1
- 150000008139 anthraquinone glycosides Chemical class 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- SZGZILRQIYNODJ-UHFFFAOYSA-L disodium;7,12-dihydroquinoxalino[3,2-b]phenazine-2,9-disulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC=C2N=C(C=C3C(NC4=CC=C(C=C4N3)S(=O)(=O)[O-])=C3)C3=NC2=C1 SZGZILRQIYNODJ-UHFFFAOYSA-L 0.000 description 1
- 238000001827 electrotherapy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 150000002338 glycosides Chemical group 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000002653 magnetic therapy Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000004423 myopia development Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000001328 optic nerve Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a Chinese medicine preparation for treating pseudomyopia, particularly to a Qianliming eye ointment which is a medicine plaster for external application. The Qianliming eye ointment has the preparation method that the Qianliming eye ointment is prepared from various Chinese herbal medicines according to a certain dosage. The preparation method comprises the steps of screening, drying, grounding, frying, decocting and concentrating medicines to form the ointment. The Qianliming eye ointment has the advantages of sterilization, and no toxicity, toxic side effect and anaphylactic reaction, and has an obvious effect of treating teenagers with pseudomyopia. Thereby, the Qianliming eye ointment is a relatively ideal specific medicine for external application at present.
Description
The present invention relates to a kind of preparation method for the treatment of the " Qianliming " oculentum that extracts by plurality of Chinese of teenage pseudomyopia eye.
Myopia is a kind of commonly encountered diseases frequently-occurring disease, generally just form in the teenager stage, in recent years, China students in middle and primary schools, bathomorphic sickness rate increases year by year, 92 years statistics of State Education Commission, students in middle and primary schools' rate of myopia is 49.47%, the adolescent myopia rate is 74.76% below 18 years old, and is ascendant trend year by year, has had a strong impact on student's physical and mental health.
Treatment myopia method is a lot of at present, for example vision correction instrument, Micropole glasses, look therapies such as happy eyeshield, laser therapy, magnetic therapy, electrotherapy, acupuncture for general, although various therapies all have certain curative effect, to a certain degree alleviate, mostly curative effect is not consolidated.Current also do not have a kind of method preferably to bathomorphic treatment.Near-sighted glasses are worn in being still of generally adopting in the society now, can correct defects of vision though wear near-sighted glasses, regulate diopter, and to the no therapeutical effect of eyes itself, and it is big more to wear its number of degrees more, can not stop the development of myopia.Currently press for medical technical field circle, for the Hope Project of motherland keeps punching, the prevention of the vast adolescent myopia oculopathy of solution as early as possible, treatment, consolidate, thorough problem such as radical cure.
The purpose of this invention is to provide a kind of evident in efficacy and without any the preparation technology of the Chinese medicine preparation " Qianliming " oculentum of the treatment pseudomyopia of side effect.
Motherland's traditional Chinese medical science thinks that myopia is the oculopathy of feature with " being clear, distant vision being blurred ", has another name called closely timid disease far away, claim that to Qing Dynasty's " order is through great achievement " primary disease is a myopia beginning, the cause of disease belongs to declination of heart-YANG more, excess of YIN due to YANG-insufficiency, refreshing light can not be sent out more in far ultraviolet in the order, thus look closely still clear, distant vision being blurred.Both liver and kidney deficiency, eyes losing nutrition, so that ophthalmocopia can not and far and only can be looked near.Successive dynasties doctor work how with discussing, thinks that as " General Treatise on the Cause and Symptoms of Diseases, the sick duke or princess under an emperor of order " order can not hypermetropia be by due to " impairment caused by overstrain internal organs, deficiency of liver-QI " to primary disease.Yuan Dynasty physician Wang Hai ensconces in " this thing difficulty is known " and then proposes: can not hypermetropia, and to blame it and do not have fire, method is worked as reinforcing the heart.To " Precious Book of Ophthalmology ", remove the forefathers' viewpoint that continues, think can not hypermetropia to be YANG deficiency and outer, also point out: myopia can be because of " the not enough kidney channel disease of Liver Channel ", and it is congenital possessing due to not enough and the heredity that this disease occurs in reason, or because of the yang-energy interior-deficiency day after tomorrow, use improper and its internal organs of impairment caused by overstrain of order again usually, the double ailment said due to cold or exposure that is subjected to is attacked the qi depression to blood stasis that causes outward, and meridians are obstructed, turbid sun is not fallen, clear YANG failing to ascend, the refreshing mistake of pupil supported, ophthalmocopia can not far reach down to brilliance, so look closely still clear, distant vision being blurred is promptly sent out the disease into myopia.
Chinese medicine is used for external treatment, has been of long standing and well established in motherland's medical science.Cure existing ancient times the earliest such as work " 52 Bingfang ", Huangdi's Internal Classics etc. all external treatment side and treatment by oral administration of medicines Fang Tongyong.Qing Dynasty's Wu Shangxian life says that in " the theoretical parallel prose " reason of external treatment is the reason of treatment by oral administration of medicines, and the medicine of external treatment is the medicine of treatment by oral administration of medicines, different person, and the method ear is reached the same goal by different routes, and this has always been the case.External treatment through the ancient Chinese medicine doctor development, has been widely used in aspects such as health care, prevention, treatment, rehabilitation slow down aging again, and is existing to become unique in a motherland's medical science branch.
The present invention is according to motherland's Chinese medicine theory, the clinical practice of the long-pending combination of Chinese and Western medicine for many years of applicant, by analyzing and concluding, find out various ophthalmics with the contact between the inherent body constitution, cure the disease according to the traditional Chinese medical science and to effect a permanent cure, inner disease outer treat, treating different diseases with the same therapeutic principle, the reason of external treatment is the reason of treatment by oral administration of medicines, the external treatment medicine is a treatment by oral administration of medicines medicine scheduling theory, consults ancient and present medicine case, secret recipe, proved recipe, in conjunction with my clinical experience, selects the essence, solely ward off new way, the therapy that the creativity and innovation " Qianliming " oculentum is new and the used medicine of treatment myopia.
The present invention is from people's integral body, immanent cause based on myopia, consolidate based on nourishing, spleen benefiting and stimulating the appetite is supported the kidney tonifying liver, blood circulation promoting and blood stasis dispelling, make eye bright and have one's ideas straightened out, assistant dredge through bleed the tying-in ascending, the effect of fragrance refreshment medicine each active ingredient disperse of guiding down strengthens and coordinates the function of each organ to each organ of body people.Traditional Chinese medical science medication combines cleverly with the acupoint massage of women's head-ornaments portion, medicine is by the infiltration and the Absorption of point skin, messenger drug along with the meridians blood vessels by the vital organs of the human body so that each position of whole body, through sick institute, simultaneously to exciting the regulation and control of meridians, cause kind blood circulation, particularly the microcirculation in eye district improves optic nerve, and the irritability of muscle recovers eye muscle adjustment movement performance therapeutical effect.
The present invention is made up of following 53 flavor Chinese medicines, and the medication ratio is as follows:
With Herba Senecionis Scandentis is 3 (same under the unit of weight), Radix Astragali 2.5-3, Fructus Lycii, Fructus Leonuri, Spica Prunellae, Folium Mori, Semen Cuscutae, Flos Chrysanthemi Indici, Flos Buddlejae, Semen Celosiae, Semen Vaccariae, Concha Haliotidis, Herba Dendrobii, Flos Eriocauli, Semen Astragali Complanati, Fructus Atriplicis Sibiricae, the Herba Equiseti Hiemalis, Caulis Spatholobi, Radix Curcumae, Radix Bupleuri, Ramulus Cinnamomi, Radix Platycodonis, Rhizoma Dioscoreae, Rhizoma Chuanxiong, Herba Ephedrae, Rhizoma Cimicifugae, Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, the Radix Rehmanniae, the Radix Paeoniae Alba, Radix Aconiti Lateralis Preparata, Poria, Niu Xi, Semen Persicae, Flos Carthami, each 1.5-2 of Radix Glycyrrhizae, Radix Ginseng, each 2-2.5 of Cornu Cervi Pantotrichum, Olibanum, each 3-3.5 of Myrrha, Os Draconis 2, Magnetitum 1, Flos Caryophylli, the Radix Aucklandiae, Lignum Aquilariae Resinatum, each 1.5-2 of Styrax, Margarita 2-2.5; Moschus, Calculus Bovis, each 1.2-1.8 part of Fel Ursi, Colophonium 20-25, Plumbum preparatium 80-85, Oleum sesami 120-130.
Modern medicine proves that vegetable oil can only dissolve some nonpolar materials.The general contained active ingredient of Chinese crude drug often combines salify with various organic acid and exists as alkaloid, so can not be dissolved in oil in cell.The alkaloid of minority free state, flavonoid glycosides, the anthraquinone glycoside though can dissolve with some glycoside unit etc., at high temperature, also destroys mostly.Resin and volatile component chance high temperature also easily decompose and volatilize, and temper but these compositions generally can not tolerate 280 ℃ of-310 ℃ of high temperature of 15 minutes.Use the gas chromatograph detection and show that volatile component is reactionless after 300 ℃ of processing of 20 minutes.According to the manufacturing defect of above-mentioned plaster, the invention reside in and overcome traditional plaster manufacture method, avoided Chinese medicinal herbs and decomposition and the loss of oil when high temperature is tempered.Concrete preparation method realizes by following scheme.
Preparation method:
Selected medicine grinds coarser powder and adopts deionized water merceration → decoction → cryoconcentration to become cream.Oil refining → alseodaphne hainanensis combination reaction liter becomes fatty acid lead salt → remove releasing fire-toxin → stir into cream → pill with water boiling concentration cream mixing low temp evaporation Ex-all moisture content → addings fines medicament mixed to package spare and store the cool place and locate.
The invention belongs to liniment, indication is teenage pseudomyopia or with the pseudomyopia of true property significant curative effect is arranged, degree of depth myopia is also had the effect of slowing down.Use this medicine to have no side effect, do not have irritated reaction.
This medicine mechanism of action: replenishing vital essence to improve eyesight inducing resuscitation, blood circulation promoting and blood stasis dispelling, expansion blood capillary and miniature blood vessel, the blood circulation of improvement eye, the circulation of qi promoting intestinal stasis relieving, meridians dredging is removed ciliary spasm, soothing the liver, nourishing kidney, so that clear positive must be long, turbid yin must fall, and the effect of QI invigorating warming YANG makes eyesight improving and raising or recovers normal fully.
Embodiment:
(1) thing of getting it filled, Herba Senecionis Scandentis, the Radix Astragali, Fructus Lycii, Fructus Leonuri, Spica Prunellae, Folium Mori, Semen Cuscutae, Flos Chrysanthemi Indici, Flos Buddlejae, Semen Celosiae, Semen Vaccariae, Concha Haliotidis, Herba Dendrobii, Flos Eriocauli, Semen Astragali Complanati, Fructus Atriplicis Sibiricae, the Herba Equiseti Hiemalis, Caulis Spatholobi, Radix Curcumae, Radix Bupleuri, Ramulus Cinnamomi, Radix Platycodonis, Rhizoma Dioscoreae, Rhizoma Chuanxiong, Herba Ephedrae, Rhizoma Cimicifugae, Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, the Radix Rehmanniae, the Radix Paeoniae Alba, Radix Aconiti Lateralis Preparata, Poria, Niu Xi, Semen Persicae, Flos Carthami, Radix Glycyrrhizae is ground coarser powder and uses deionized water merceration 3 hours, the each decoction 45 minutes to 50 minutes, decoct altogether three times, with three times fried liquid elimination slag, mix, leave standstill, sedimentation, filtration, purification is handled the back cryoconcentration and is become cream;
(2) thing of getting it filled, Radix Ginseng, Cornu Cervi Pantotrichum list are fried in shallow oil, and are to protect the medicine active ingredient, in case by the absorption of the slag of other medicines, decoct medicinal liquid elimination slags through three times and participate in concentrating in the above-mentioned decocting liquid;
(3) thing of getting it filled, Olibanum, Myrrha, Os Draconis, Magnetitum, Flos Caryophylli, the Radix Aucklandiae, Lignum Aquilariae Resinatum, Styrax each, Margarita, Moschus, Calculus Bovis, Fel Ursi, Colophonium grind impalpable powder (120 orders sieve) altogether and claim the fines medicine;
(4) thing of getting it filled, Plumbum preparatium, Oleum sesami, refine oil, earlier with oil 220 ℃ to 320 ℃ refinings to dripping into pearl Plumbum preparatium at present, Oxidation of Fat and Oils polyreaction under 316 ℃ of temperature, rise into the fatty acid lead salt and form cream, treat when temperature is reduced to 150 ℃ the cream base that is smelt slowly to be removed releasing fire-toxin with thread impouring cold water again;
(5) cream base of getting with releasing fire-toxin mixes with water boiling concentration cream, evaporates 100 ℃ of-120 ℃ of temperature and removes institute's water content in the plaster;
(6) get fines medicine and Storax oil and add mix homogeneously in the plaster of having removed moisture content, 65 ℃ of-70 ℃ of the bests of mixing temperature;
(7) get above-mentioned plaster and make pill, diameter is 7mm, every heavy 0.55g, and softening point is 55 ℃-60 ℃;
(8) packaging and storing shady and cool place keeping.
Use embodiment:
Getting 10 of medicine-feedings applies ointment or plaster respectively and encloses on the acupuncture point near the eyes facial two, fix with medical proof fabric, massage its acupuncture point by the stimulation of medicine to the acupuncture point, excite gas through the cave, impel its performance best drug influence and the effect of two-way accent do, blood circulation promoting is removed spasm of ocular muscles, can directly cause the vasodilation of being controlled the position, blood flow is accelerated, blood circulation is improved, obtain the good result of " visual acuity is obtained from the sufficient blood supply of the eyes ", thereby make channels and collaterals dredging, regulating and controlling effect strengthens, function of ocular muscle is improved, from therapeutic effect, be 95% to the effective percentage of pseudomyopia, cure rate is more than 90%, and healing time is short, instant effect can be consolidated after the treatment for a long time, and is without any side effects.
There is following each cave at bathomorphic treatment acupuncture point: behind te 23, Yuyao, Zanzhu, Jingming, Sibai, chengqi, the ball, fish tail, gb 1
Ear eye, order 1, order 2, order 3.
Claims (1)
1. the preparation method of a " Qianliming " oculentum, it is characterized in that: this method comprises the steps:
(1) with weight is get it filled 3 parts of thing Herba Senecionis Scandentis of unit, Radix Astragali 2.6-3 part, Fructus Lycii, Fructus Leonuri, Spica Prunellae, Folium Mori, Semen Cuscutae, Flos Chrysanthemi Indici, Flos Buddlejae, Semen Celosiae, Semen Vaccariae, Concha Haliotidis, Herba Dendrobii, Flos Eriocauli, Semen Astragali Complanati, Fructus Atriplicis Sibiricae, the Herba Equiseti Hiemalis, Caulis Spatholobi, Radix Curcumae, Radix Bupleuri, Ramulus Cinnamomi, Radix Platycodonis, Rhizoma Dioscoreae, Rhizoma Chuanxiong, Herba Ephedrae, Rhizoma Cimicifugae, Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, the Radix Rehmanniae, the Radix Paeoniae Alba, Radix Aconiti Lateralis Preparata, Poria, Radix Achyranthis Bidentatae, Semen Persicae, Flos Carthami, each 1.5-2 part of Radix Glycyrrhizae is ground coarser powder and is used deionized water merceration 3 hours, the each decoction 45 minutes to 50 minutes, decoct altogether three times, with three times fried liquid elimination slag, mix, leave standstill, sedimentation, filtration, purification is handled the back cryoconcentration and is become cream;
(2) thing of getting it filled, Radix Ginseng, each 2-2.5 part of Cornu Cervi Pantotrichum are singly fried in shallow oil, through decoct for three times medicinal liquid elimination slag mix with above-mentioned decocting liquid in concentrate;
(3) thing of getting it filled, Olibanum, each 3-3.5 part of Myrrha, 2 parts of Os Draconis, 1 part of Magnetitum, Flos Caryophylli, the Radix Aucklandiae, Lignum Aquilariae Resinatum, each 1.5-2 part of Styrax, Margarita 2-2.5 part, Moschus, Calculus Bovis, each 1.2-1.8 part of Fel Ursi, Colophonium 20-25 part are ground impalpable powder altogether, and 120 orders that sieve become the fines medicine;
(4) thing of getting it filled, Plumbum preparatium 80-85 part, Oleum sesami 120-130 part, refine oil, earlier with oil 220 ℃ to 320 ℃ refinings to dripping into pearl Plumbum preparatium at present, Oxidation of Fat and Oils polyreaction under 316 ℃ of temperature, generate the fatty acid lead salt and form cream, treat when temperature is reduced to 150 ℃ the cream base that is smelt slowly to be removed releasing fire-toxin with thread impouring cold water again;
(5) cream base of getting with releasing fire-toxin mixes with water boiling concentration cream, evaporates 100 ℃ of-120 ℃ of temperature and removes institute's water content in the plaster;
(6) get fines medicine and Storax oil and add mix homogeneously in the plaster of having removed moisture content, 65 ℃-70 ℃ of mixing temperatures;
(7) get above-mentioned plaster and make pill, diameter is 7mm, every heavy 0.55g, and softening point is 55 ℃-60 ℃.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 94114836 CN1037237C (en) | 1994-08-11 | 1994-08-11 | "Qianliming" oculentum |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 94114836 CN1037237C (en) | 1994-08-11 | 1994-08-11 | "Qianliming" oculentum |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1105879A CN1105879A (en) | 1995-08-02 |
| CN1037237C true CN1037237C (en) | 1998-02-04 |
Family
ID=5037210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 94114836 Expired - Fee Related CN1037237C (en) | 1994-08-11 | 1994-08-11 | "Qianliming" oculentum |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1037237C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100389791C (en) * | 2007-08-13 | 2008-05-28 | 林继华 | Eye drops and preparation method thereof |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1325086C (en) * | 2005-06-14 | 2007-07-11 | 吉林长白山药业集团股份有限公司 | Bear gall eyesight-improving tablet |
| CN101647908B (en) * | 2009-09-27 | 2011-06-15 | 贾晓萍 | Chinese traditional medicine for treating eyesight and preparation method and use method thereof |
| CN103393969B (en) * | 2013-08-03 | 2015-01-07 | 吴春子 | Eye drop used for releasing eye fatigue and preparation method thereof |
| CN104524122A (en) * | 2014-12-20 | 2015-04-22 | 陈晓霞 | Traditional Chinese medicine preparation for treating radiation cataract and preparation method |
| CN107789617A (en) * | 2017-11-16 | 2018-03-13 | 北京德尚悦目科技有限公司安徽分公司 | A kind of selenium peptide improving eyesight eye refreshing drop and preparation method thereof |
| CN108969558A (en) * | 2018-09-06 | 2018-12-11 | 李阿妮 | A kind of Chinese traditional medicine composition ointment and preparation method thereof for treating near-sighted long sight amblyopia presbyopic |
-
1994
- 1994-08-11 CN CN 94114836 patent/CN1037237C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100389791C (en) * | 2007-08-13 | 2008-05-28 | 林继华 | Eye drops and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1105879A (en) | 1995-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1085792A (en) | Treat bathomorphic liniment and preparation method thereof | |
| CN103768283A (en) | Traditional Chinese medicine for treating multiple eye diseases | |
| CN102614444A (en) | Oral solution for effective treatment of drunkenness syndrome | |
| CN111035748A (en) | Traditional Chinese medicine composition for improving myopia, external application preparation for improving myopia and eye patch for improving myopia | |
| CN1037237C (en) | "Qianliming" oculentum | |
| CN101642511B (en) | Traditional Chinese medicine composition for relieving visual fatigue and treating pseudomyopia and preparation method thereof | |
| CN103933503A (en) | Oolong tougu plaster and preparation method thereof | |
| CN1178682A (en) | Chinese drug Mingmudan pill for improving eyesight and its producing method | |
| CN102370830B (en) | Eyesight-improving massage Chinese medicinal preparation and preparation method thereof | |
| CN111558031B (en) | Pure plant multifunctional eye special nutrient solution and preparation method thereof | |
| CN102178908B (en) | Preparation method of traditional Chinese medicine for treating over fatigue cold injury | |
| CN104524038A (en) | Traditional Chinese medicine composition for preventing and treating shortsightedness and application method thereof | |
| CN107519314A (en) | It is a kind of to be used to treat ointment of myopia and preparation method thereof | |
| CN112076268A (en) | Traditional Chinese medicine lotion for preventing and treating alopecia and blackening hair, preparation method and application | |
| CN1109786A (en) | Method of manufacturing eyesight-improving bag for navel treatment | |
| CN102935162B (en) | Pills for retrobulbar neuritis and preparation method | |
| CN1201811C (en) | Chinese medicine composition for treating myopia and preparing method thereof | |
| CN107260978B (en) | A kind of traditional Chinese medicine composition for treating hypertension, preparation method and use thereof | |
| CN115089633B (en) | Composition for preventing and treating myopia, eye mask and preparation method | |
| CN103341054B (en) | Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases and preparation method thereof | |
| CN102225105B (en) | Medicine for treating migraine | |
| CN102727668A (en) | Chinese medicine composition with effect of alleviating asthenopia and preparation method thereof | |
| CN108498615A (en) | A kind of Chinese herb medicine eye health-care patch and preparation method thereof improving eyes based on nitric oxide principle | |
| CN119679913A (en) | A medicine for treating soreness, heaviness and numbness of waist, shoulder and cervical vertebra and its preparation method | |
| CN107184747A (en) | Prevent and treat Chinese medicine composition, Wet-dressing agent of myopia and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent for invention or patent application | ||
| CB02 | Change of applicant information |
Address after: Gaizhou, Liaoning province Gaizhou Town, Xiguan West 70-0, Gaizhou on the first floor of the pharmaceutical building on the North Wing Applicant after: Lin Jihua Address before: 502, room 2, building 072750, Twin Towers Credit Union, 3 Jing Guang road, Hebei, Zhuozhou Applicant before: Liu Shurong |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: LIU SHURONG; ROOM 502, UNIT 2, SHUANGTAXINYONGSHEJIASHU HOUSE, NO. 3, JINGGUANG ROAD, ZHUOZHOU CITY, HEBEI PROVINCE, 072750 TO: LIN JIHUA; HOUSE 1, BEIGUANYIYAO BUILDING, GAI STATE CITY, NO. 70-0, XIGUANBEILI, GAI STATE TOWN, GAIZHOU CITY, LIAONING PROVINCE |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Lin Jihua Document name: Notification to Pay the Fees |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20081128 Address after: No. 76, unity Road, Shenhe District, Shenyang, Liaoning Patentee after: Liaoning Qianliming Pharmaceutical (Group) Co., Ltd. Address before: Gaizhou, Liaoning province Gaizhou Town, Xiguan West 70-0, Gaizhou on the first floor of the pharmaceutical building on the North Wing Patentee before: Lin Jihua |
|
| ASS | Succession or assignment of patent right |
Owner name: LIAONING QIANLIMING PHARMACY ( GROUP ) CO., LTD. Free format text: FORMER OWNER: LIN JIHUA Effective date: 20081128 |
|
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 19980204 Termination date: 20100811 |